Viral Hepatitis Testing Act of 2013

H.R. 3723 - Viral Hepatitis Testing Act S. 2538 - Viral Hepatitis Testing Act Biosimilars FDA ReformH.R. 83 - Consolidated and Further Continuing Appropriations Act, 2015

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Discussions and proposals related to the 21st Century Cures initiative; Discussions to clarify or reform the 340B program; Biologics Price Competition and Innovation Act; H.R. 3723, Viral Hepatitis Testing Act of 2013; S. 2538, Viral Hepatitis Testing Act of 2014; Proposals to improve viral hepatitis screening and testing; Public Law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Health Care and Education Reconciliation Act of 2010; Proposals to address prescription drug abuse; Implementation of The Prescription Drug User Fee Act (PDUFA);

Client expense: $1,010,000 · Firm income: Not reported

HR 45-To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act of 2010: entire bill HR 132: ObamaCare Repeal Act: entire bill Public Law No. 111-148- Patient Protection and Affordable Care Act: entire law Public Law No. 111-152- Health Care and Education Reconciliation Act of 2010: entire law HR 2457- Womens Preventive Health Awareness Campaign Act: entire bill HR 1975- Pregnant Workers Fairness Act: entire bill S. 942- Pregnant Workers Fairness Act: entire bill HR 2632- School-based Health Centers Program Reauthorization Act of 2013: entire bill HR 2676- Medicaid Information Technology to Enhance Community Health Act of 2013: entire bill S. 1286- Medicaid Information Technology to Enhance Community Health Act of 2013: entire bill HR 2810- To amend title XVIII of the Social Security Act to reform the sustainable growth rate and Medicare payment for physicians' services, and for other purposes: amendments and provisions related to and affecting reproductive health and family planning S. 1871- SGR Repeal and Medicare Beneficiary Access Act of 2013: amendments and provisions related to and affecting reproductive health and family planning S. 1871- SGR Repeal and Medicare Beneficiary Access Act of 2013: amendments and provisions related to and affecting reproductive health and family planning S. 1009 - Chemical Safety Improvement Act: entire bill HR 4302- Protecting Access to Medicare Act: amendments and provisions related to and affecting reproductive health and family planning HR 3723 - Viral Hepatitis Testing Act of 2013: entire bill HR 5364/S 2461 - Amend title XXI of the Social Security Act to extend and improve the CHIP Program: entire bill HR 5353 - Amend title XIX of the Social Security Act to extend for 5 years payment parity with Medicare for primary care services: Entire bill HR 5380 - Medicare Parity Act: entire bill S 2662 - Telehealth Enhancement Act of 2014: entire bill HR 5481 - To continue the use of a 3-month quarter EHR reporting period for health care providers to demonstrate meaningful use for 2015 under the Medicare and Medicaid EHR incentive payment programs, and for other purpose (Flexibility in Health IT Reporting (Flex-IT) Act of 2014"): entire bill S 2629 - Preventive Care Coverage Notification Act: entire bill S 2694 - Ensuring Access to Primary Care for Women & Children Act: entire bill S 2908 - A bill to amend the Internal Revenue Code of 1986 to expand eligibility for the refundable credit for coverage under a qualified health plan, and for other purposes: entire bill S 2578/ HR 5150 - Protect Women's Health From Corporate Interference Act: entire bill HR 5294 - Health Equity and Accountability Act HR 5723 - Ensuring Access to Primary Care for Women & Children Act

Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation. H.R. 3723, Viral Hepatitis Testing Act of 2013.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

**see addendum pageH.R. 3204 - The Drug Quality and Security Act, implementation H.R. 3723 - Viral Hepatitis Testing Act of 2013 no specific bill - FDA implementation issues, 340B, biosimilars, 21st Century Cures

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 3723: Viral Hepatitis Testing Act. Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars. Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures).Education about the value of innovative new medicines.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3723 - Viral Hepatitis Testing Act S. 2538 - Viral Hepatitis Testing Act Biosimilars

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3723 - Viral Hepatitis Testing Act S. 2538 - Viral Hepatitis Testing Act Biosimilars

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.J. Res 59, Continuing Appropriations Resolution, regarding all biopharmaceutical related provisions. Labor, HHS Appropriations, regarding all biopharmaceutical related provisions. Agriculture appropriations, regarding all biopharmceutical related provisions. H.R. 2725/S. 1413, FDA Safety over Sequestration Act, regarding all biopharmaceutical user-fees. No-bill, educational meetings regarding atrial fibrillation. No bill - regarding FDA regulatory issues and patent incentives related to the 21st Century Cures Initiative. Health Care Reform implementation - regarding essential health benefits coverage and all biopharmaceutical related provisions. H.R. 3723, Viral Hepatitis Testing Act, regarding all provisions.

Client expense: $770,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

H.J. Res 59, Continuing Appropriations Resolution, regarding all biopharmaceutical related provisions. Labor, HHS Appropriations, regarding all biopharmaceutical related provisions. Agriculture appropriations, regarding all biopharmceutical related provisions. H.R. 2725/S. 1413, FDA Safety over Sequestration Act, regarding all biopharmaceutical user-fees. No-bill, educational meetings regarding atrial fibrillation. No bill - regarding FDA regulatory issues and patent incentives related to the 21st Century Cures Initiative. Health Care Reform implementation - regarding essential health benefits coverage and all biopharmaceutical related provisions. H.R. 3723, Viral Hepatitis Testing Act, regarding all provisions.

Client expense: Not reported · Firm income: $770,000

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

H.R.3723, Viral Hepatitis Testing Act of 2013. Issues related to the FDA, including generic products, labeling, etc. Coverage of pharmaceuticals, cost-sharing and other access issues.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Viral Hepatitis/HIV/AIDS Hep Action Plan H.R. 3723/S. 2538: Viral Hepatitis Testing Act Substance Abuse testing CMS Reimbursement

Client expense: Not reported · Firm income: $10,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)

HR 45-To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act of 2010: entire bill HR 132: ObamaCare Repeal Act: entire bill Public Law No. 111-148- Patient Protection and Affordable Care Act: entire law Public Law No. 111-152- Health Care and Education Reconciliation Act of 2010: entire law HR 2457- Womens Preventive Health Awareness Campaign Act: entire bill HR 1975- Pregnant Workers Fairness Act: entire bill S. 942- Pregnant Workers Fairness Act: entire bill HR 2632- School-based Health Centers Program Reauthorization Act of 2013: entire bill HR 2676- Medicaid Information Technology to Enhance Community Health Act of 2013: entire bill S. 1286- Medicaid Information Technology to Enhance Community Health Act of 2013: entire bill HR 2810- To amend title XVIII of the Social Security Act to reform the sustainable growth rate and Medicare payment for physicians' services, and for other purposes: amendments and provisions related to and affecting reproductive health and family planning S. 1871- SGR Repeal and Medicare Beneficiary Access Act of 2013: amendments and provisions related to and affecting reproductive health and family planning S. 1871- SGR Repeal and Medicare Beneficiary Access Act of 2013: amendments and provisions related to and affecting reproductive health and family planning S. 1009 - Chemical Safety Improvement Act: entire bill HR 4302- Protecting Access to Medicare Act: amendments and provisions related to and affecting reproductive health and family planning HR 3723 - Viral Hepatitis Testing Act of 2013: entire bill HR 5364/S 2461 - Amend title XXI of the Social Security Act to extend and improve the CHIP Program: entire bill HR 5353 - Amend title XIX of the Social Security Act to extend for 5 years payment parity with Medicare for primary care services: Entire bill HR 5380 - Medicare Parity Act: entire bill S 2662 - Telehealth Enhancement Act of 2014: entire bill HR 5481 - To continue the use of a 3-month quarter EHR reporting period for health care providers to demonstrate meaningful use for 2015 under the Medicare and Medicaid EHR incentive payment programs, and for other purpose (Flexibility in Health IT Reporting (Flex-IT) Act of 2014"): entire bill S 2629 - Preventive Care Coverage Notification Act: entire bill S 2694 - Ensuring Access to Primary Care for Women & Children Act: entire bill S 2908 - A bill to amend the Internal Revenue Code of 1986 to expand eligibility for the refundable credit for coverage under a qualified health plan, and for other purposes: entire bill S 2578/ HR 5150 - Protect Women's Health From Corporate Interference Act: entire bill HR 5294 - Health Equity and Accountability Act

H.R. 3723 - Viral Hepatitis Testing Act S. 2538 - Viral Hepatitis Testing Act Biosimilars

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation. H.R. 3723, Viral Hepatitis Testing Act of 2013.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3723: Viral Hepatitis Testing Act. Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars. Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures).Education about the value of innovative new medicines.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

**see addendum pageH.R. 3204 - The Drug Quality and Security Act, implementation H.R. 3723 - Viral Hepatitis Testing Act of 2013 no specific bill - FDA implementation issues, 340B, biosimilars, 21st Century Cures

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Public Law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Reconciliation Act of 2010; BPCIA (biosimilars); H.R. 3723, Viral Hepatitis Testing Act of 2013; Proposals to improve viral hepatitis screening and testing; H.R. 3204, Drug Quality & Security Act of 2013; S. 957, Drug Supply Chain Security Act; S. 621, Safe Prescribing Act of 2013; H. R. 1285, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug; Discussions to clarify or reform the 340B program; Implementation of The Prescription Drug User Fee Act (PDUFA); H.R. 2031, TEST Act

Client expense: $1,600,000 · Firm income: Not reported

H.J. Res 59, Continuing Appropriations Resolution, regarding all biopharmaceutical related provisions. Labor, HHS Appropriations, regarding all biopharmaceutical related provisons. Agriculture approrpiations, regarding all biopharmceutical related provisions.H.R. 2725/S. 1413, FDA Safety over Sequestration Act, regarding all biopharmaceutical user-fees. No-bill, educational meetings regarding atrial fibrillation. No bill - regarding FDA regulatory issues and patent incentives related to the 21st Century Cures Initiative. Health Care Reform implementation - regarding essential health benefits coverage and all biopharmaceutical related provisions. H.R. 3723, Viral Hepatitis Testing Act, regarding all provisions.

Client expense: $680,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

Viral Hepatitis/HIV/AIDS Hep Action Plan H.R. 3723: Viral Hepatitis Testing Act CMS Reimbursement Substance Abuse testing

Client expense: Not reported · Firm income: $10,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)

H.R.3723, Viral Hepatitis Testing Act of 2013. Issues related to the FDA, including generic products, labeling, etc. Coverage of pharmaceuticals, cost-sharing and other access issues.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 3723 - Viral Hepatitis Testing Act S. 2538 - Viral Hepatitis Testing Act Biosimilars

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 45-To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act of 2010: entire bill HR 132: ObamaCare Repeal Act: entire bill Public Law No. 111-148- Patient Protection and Affordable Care Act: entire law Public Law No. 111-152- Health Care and Education Reconciliation Act of 2010: entire law HR 2457- Womens Preventive Health Awareness Campaign Act: entire bill HR 1975- Pregnant Workers Fairness Act: entire bill S. 942- Pregnant Workers Fairness Act: entire bill HR 2632- School-based Health Centers Program Reauthorization Act of 2013: entire bill HR 2676- Medicaid Information Technology to Enhance Community Health Act of 2013: entire bill S. 1286- Medicaid Information Technology to Enhance Community Health Act of 2013: entire bill HR 2810- To amend title XVIII of the Social Security Act to reform the sustainable growth rate and Medicare payment for physicians' services, and for other purposes: amendments and provisions related to and affecting reproductive health and family planning S. 1871- SGR Repeal and Medicare Beneficiary Access Act of 2013: amendments and provisions related to and affecting reproductive health and family planning S. 1871- SGR Repeal and Medicare Beneficiary Access Act of 2013: amendments and provisions related to and affecting reproductive health and family planning S. 1009 - Chemical Safety Improvement Act: entire bill HR 4302- Protecting Access to Medicare Act: amendments and provisions related to and affecting reproductive health and family planning HR 3723 - Viral Hepatitis Testing Act of 2013: entire bill

Client expense: $403,685 · Firm income: Not reported

Public Law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Reconciliation Act of 2010; BPCIA (biosimilars); H.R. 3723, Viral Hepatitis Testing Act of 2013; Proposals to improve viral hepatitis screening and testing; H.R. 3204, Drug Quality & Security Act of 2013; S. 957, Drug Supply Chain Security Act; S. 621, Safe Prescribing Act of 2013; H. R. 1285, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug;Discussions to clarify or reform the 340B program; Implementation of The Prescription Drug User Fee Act (PDUFA);

Client expense: $880,000 · Firm income: Not reported

Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation. H.R. 3723, Viral Hepatitis Testing Act of 2013.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3723: Viral Hepatitis Testing Act. Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars. Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures).Education about the value of innovative new medicines. Proposed changes to generic drug labeling.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

**see addendum pageH.R. 3204 - The Drug Quality and Security Act, implementation H.R. 3723 - Viral Hepatitis Testing Act of 2013 no specific bill - FDA implementation issues, 340B, biosimilars, 21st Century Cures

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.J. Res 59, Continuing Appropriations Resolution, regarding all biopharmaceutical related provisions. Labor, HHS Appropriations, regarding all biopharmaceutical related provisons. Agriculture approrpiations, regarding all biopharmceutical related provisions.H.R. 2725/S. 1413, FDA Safety over Sequestration Act, regarding all biopharmaceutical user-fees. No-bill, edcuational meetings regarding atrial fibrilation. No bill - regarding FDA regulatory issues and patent incentives related to the 21st Century Cures Initiative. Health Care Reform implementation - regarding essential health benefits coverage and all biopharmaceutical related provisions. H.R. 3723, Viral Hepatitis Testing Act, regarding all provisions.

Client expense: $775,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

H.R.3723, Viral Hepatitis Testing Act of 2013. Issues related to the FDA, including generic products, labeling, etc.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Viral Hepatitis/HIV/AIDS Hep Action Plan H.R. 3723: Viral Hepatitis Testing Act CMS ReimbursementSubstance Abuse testing

Client expense: Not reported · Firm income: $10,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)

HR 45To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act of 2010: entire bill HR 132: ObamaCare Repeal Act: entire billPublic Law No. 111-148 Patient Protection and Affordable Care Act: entire law Public Law No. 111-152 Health Care and Education Reconciliation Act of 2010: entire law HR 2457 Womens Preventive Health Awareness Campaign Act: entire bill HR 1975 Pregnant Workers Fairness Act: entire bill S. 942 Pregnant Workers Fairness Act: entire bill HR 2632 School-based Health Centers Program Reauthorization Act of 2013: entire bill HR 2676 Medicaid Information Technology to Enhance Community Health Act of 2013: entire bill S. 1286 Medicaid Information Technology to Enhance Community Health Act of 2013: entire bill HR 2810 To amend title XVIII of the Social Security Act to reform the sustainable growth rate and Medicare payment for physicians' services, and for other purposes: amendments and provisions related to and affecting reproductive health and family planning S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013: amendments and provisions related to and affecting reproductive health and family planning S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013: amendments and provisions related to and affecting reproductive health and family planning S. 1009 Chemical Safety Improvement Act: entire bill HR 4302 Protecting Access to Medicare Act: amendments and provisions related to and affecting reproductive health and family planning HR 3723 Viral Hepatitis Testing Act of 2013: entire bill

Client expense: $61,957 · Firm income: Not reported

Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation. H.R. 3723, Viral Hepatitis Testing Act of 2013.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Public Law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Reconciliation Act of 2010; BPCIA (biosimilars); H.R. 3723, Viral Hepatitis Testing Act of 2013; Proposals to improve viral hepatitis screening and testing; H.R. 3204, Drug Quality & Security Act of 2013; S. 957, Drug Supply Chain Security Act; S. 621, Safe Prescribing Act of 2013; H. R. 1285, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug;Discussions to clarify or reform the 340B program; Implementation of The Prescription Drug User Fee Act (PDUFA);

Client expense: $1,450,000 · Firm income: Not reported

**see addendum pageH.R. 3204 - The Drug Quality and Security Act, implementation H.R. 3723 - Viral Hepatitis Testing Act of 2013 no specific bill - FDA implementation issues, 340B, biosimilars

Client expense: Not reported · Firm income: $50,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R.3723, Viral Hepatitis Testing Act of 2013. Issues related to the FDA, including generic products, labeling, etc.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Viral Hepatitis/HIV/AIDS Hep Action Plan H.R. 3723: Viral Hepatitis Testing Act CMS ReimbursementSubstance Abuse testing

Client expense: Not reported · Firm income: $10,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)

H.R. 3723: Viral Hepatitis Testing Act. Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Public Law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Reconciliation Act of 2010; BPCIA (biosimilars); S. 621, Safe Prescribing Act of 2013; H. R. 1285, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug; H.R. 3204, Drug Quality & Security Act of 2013; S. 957, Drug Supply Chain Security Act; H.R. 3723, Viral Hepatitis Testing Act of 2013; Proposals to improve viral hepatitis screening and testing;Discussions to clarify or reform the 340B program

Client expense: $600,000 · Firm income: Not reported